Eisai
4523.T
#1830
Rank
NZ$15.29 B
Marketcap
$54.24
Share price
-2.00%
Change (1 day)
-39.03%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.54

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.72. In 2022 the company made an earnings per share (EPS) of $2.73 a decrease over its 2021 EPS that were of $12.14.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.5429.47%
2022$2.73-77.48%
2021$12.14-41.88%
2020$20.89-0.94%
2019$21.0852.59%
2018$13.82124.17%
2017$6.16-49.42%
2016$12.1937.08%
2015$8.89-11.75%
2014$10.07-3.23%
2013$10.41-18.56%
2012$12.78-15.51%
2011$15.13-3.75%
2010$15.72-1.36%
2009$15.94